ArticleNPJ breast cancer2021

Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer.

Maitri Kalra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.